Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05358574

PMCF Study on the Safety, Performance and Clinical Benefits Data of the Anatomical Shoulder Bipolar System

The study is a monocentric, retrospective and prospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to collect long-term data confirming safety, performance and clinical benefits of the Anatomical Shoulder Bipolar System (Implants and Instrumentation) when used as a salvage solution in shoulder replacement.

The primary objective is the assessment of safety by analyzing implant survivorship. This will be established by recording the incidence and frequency of revisions, complications and adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified.

The secondary objective is the assessment of performance and clinical benefits by recording patient-reported clinical outcome measures (PROMs) as well as radiographic outcomes.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Helios ENDO-Klinik

Hamburg, 22767, Germany

Location status: Recruiting

Location contact

Jörg Neumann, Dr.med

CONTACT

Jörg Neumann, Dr.med

PRINCIPAL_INVESTIGATOR

About this study

The Anatomical Shoulder Bipolar System is intended for hemi shoulder replacement as a salvage solution in situations, where a Zimmer Anatomical Shoulder Inverse/Reverse prosthesis was originally planned, but it is intra-operatively found that the attachment of the Zimmer Anatomical Shoulder Inverse/Reverse glenoid fixation is not possible. The system is intended for long-term implantation into the human shoulder joint.

One site will be involved in this study. The aim is to include a maximum of 40 consecutive series cases who received the Anatomical Shoulder Bipolar starting from 2009 until 2020. All potential study subjects will be required to participate in the Informed Consent Process.

Baseline data from the preop, intraop and immediate post-op intervalls will be available in medical notes and collected retrospectively. During follow-up visits at 1, 2, 5, 7 and 10 years post-op (depending on patients' date of surgery), the patient will be asked to complete patient questionnaires. Moreover, a clinical assessment and a radiographic evaluation will be conducted. In addition, any complications and adverse events will also be collected during these follow-up visits.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The Anatomical Should Bipolar Adaptor is indicated for hemi shoulder replacement as a salvage solution in situations, where a Zimmer Anatomical Shoulder Inverse/Reverse prosthesis was originally planned, but it is intra-operatively found that the attachment of the Zimmer Anatomical Shoulder Inverse/Reverse glenoid fixation is not possible
  • Patient should have received the Anatomical Shoulder Bipolar System
  • Patient should have signed the Informed Consent Form
  • Patient is 18-100 years of age, inclusive
  • Patient is skeletally mature

Exclusion criteria

  • Patients who are not willing to return for study required follow-up visits and/or are not willing to comply with the follow-up schedule
  • Patients who have any condition which would in the judgement of the Investigator place the patient at undue risk or interfere with the study. Any patient who is institutionalized, or is a known drug abuser, a known alcoholic or anyone who cannot understand what is required of them
  • Patient is known to be pregnant or breastfeeding
  • Musculoskeletal situation that enables the application of a regular hemi or total shoulder system
  • Good quantity or quality of the glenoid bone, where the fixation of a Zimmer Anatomical Shoulder Inverse/Reverse glenoid fixation is possible
  • Patient's physical conditions that would impair achieving adequate implant support, and/or prevent the use of an appropriately sized implant (e.g. due to insufficient quality or quantity of bone).
  • Signs of infection
  • Non-functional deltoid muscle
  • Charcot's shoulder (neuroarthropathy)
  • Presence of significant injury to the upper brachial plexus
  • Any neuromuscular or vascular disease compromising the affected limb that would endanger the success of the intervention

Treatment and study plan

Primary outcomes

  1. Incidence and frequency of revisions [Product safety based on implant survivorship]

    Time frame: From operation to study completion, 1-10 years

    Safety will be assessed by recording and analyzing the incidence and frequency of revisions, complications and adverse events. A Kaplan Meier survival curve will be calculated.

Secondary outcomes

  1. Constant and Murley Score

    Time frame: From post-operative to final follow-up visit, 1-10 years

    The patient will be evaluated at each interval (1, 2, 5, 7, 10 years) The Constant and Murley score is a 100-point functional shoulder assessment tool in which higher scores reflect increased function. The subjective variables are pain (15 points) and function (activities of daily living - sleep, work, recreation/sport; 20 points), for a total of 35 points. The objective variables are active range of motion (clinician assessment; 40 points) and strength (25 points), for a total of 65 points.

  2. Oxford Shoulder Score

    Time frame: From post-operative to final follow-up visit, 1-10 years

    The patient will be evaluated at each interval (1, 2, 5, 7, 10 years) The OSS is a self-assessment of shoulder pain and function with 12 items; pain (2), interference with pain (2), and daily functions (8). Each response is answered with a five point Likert scale. The total score is the sum of the 12 items, with lower scores indicating a more favorable outcome.

  3. EuroQol Five Dimensions Questionnaire

    Time frame: From post-operative to final follow-up visit, 1-10 years

    The patient will be evaluated at each interval (1, 2, 5, 7, 10 years)

    The EQ-5D measures 5 dimensions; mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, with a total of 5 questions. It is accompanied by the patient's self-assessment with the VAS.

    Each dimension is assigned one of three discrete levels for evaluation on the day of administration:

    Level 1 - No problems, no disability Level 2 - Some problems, moderate disability Level 3 - A lot of problems, severe disability

    The final score is a five digit composite of the responses ranging between 33333 - 11111 with 243 possible combinations in between.

  4. X-rays

    Time frame: From post-operative to final follow-up visit, 1-10 years

    Performance and clinical benefits will be assessed by radiographic evaluation. Radiographs (A/P and axillary view) of the operated shoulder will be taken at each interval.

Study contacts

Contact information is provided by the study sponsor or research team.

Julie Nicoux

CONTACT

[email protected]

+330672613502

Sponsors and collaborators

Lead sponsor

Zimmer Biomet

Industry

Registry information

Official study title

Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Anatomical Shoulderᵀᴹ Bipolar System (Implants and Instrumentation) - A Retrospective and Prospective Consecutive Series Study

Important dates

Study start
2022
Primary completion
2033
Study completion
2033
First posted
May 3, 2022
Registry last updated
Nov 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.